Prescription drug · NDA AUTHORIZED GENERIC
Dronabinol NDC 67877-755
Dronabinol 10 mg/1 · Capsule · Oral · Ascend Laboratories, LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 67877-755-60 | 67877075560 | 60 CAPSULE in 1 BOTTLE (67877-755-60)Marketed from Mar 3, 2021 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Dronabinol
- Generic name (nonproprietary)
- dronabinol
- Active ingredients
- Dronabinol — 10 mg/1
- Dosage form
- Capsule
- Route
- Oral
- Labeler
- Ascend Laboratories, LLCNDC labeler code 67877
- Product type
- Prescription drug
- Marketing category
- NDA authorized genericApplication NDA 018651
- Marketing start
- Listing expires
- DEA schedule
- CIII
- Other FDA classes
- Cannabinoids (Chemical structure)
- Identifiers
- Product ID 67877-755_97b6c4dc-59b5-4ee6-b296-26ccdf9ef853SPL ID 97b6c4dc-59b5-4ee6-b296-26ccdf9ef853SPL set ID adb1801c-0fb5-4e16-b969-1db91230e0b9RxCUI 197634, 197635, 197636UNII 7J8897W37SUPC 0367877753607, 0367877754604, 0367877755601
- Pharmacologic class
- Cannabinoid
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N467877075560followed by a unit qualifier and the quantityPackage 67877-0755-60. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Dronabinol capsules are indicated in adults for the treatment of: anorexia associated with weight loss in patients with Acquired Immune Deficiency Syndrome (AIDS). nausea and vomiting associated with cancer chemotherapy in patients who have failed to respond adequately to conventional antiemetic treatments. Dronabinol capsules is a cannabinoid indicated in adults for the treatment of: Anorexia associated with weight loss in patients with AIDS. ( 1 ) Nausea and vomiting associated with cancer chemotherapy in patients who have failed to respond adequately to conventional antiemetic treatments. ( 1 )
Excerpt only. Read the full label for complete information.
About NDC 67877-755
- What is NDC 67877-755?
- 67877-755 is the product NDC for Dronabinol, Dronabinol 10 mg/1 capsule, listed with the FDA by Ascend Laboratories, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Dronabinol.
- What is the active ingredient?
- Dronabinol.
- Who is the labeler?
- Ascend Laboratories, LLC, NDC labeler code 67877. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Dronabinol?
- 9 other product NDCs are listed under this name. See all Dronabinol NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Dronabinol products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Dronabinol | Dronabinol 5 mg/mL | SolutionOral | Wellhouse Pharma, LLC | 85776-202 | 85776-0202-30 |
| Dronabinol | Dronabinol 5 mg/1 | CapsuleOral | Major Pharmaceuticals | 0904-7145 | 00904-7145-04 |
| Dronabinol | Dronabinol 2.5 mg/1 | CapsuleOral | Ascend Laboratories, LLC | 67877-753 | 67877-0753-60 |
| Dronabinol | Dronabinol 5 mg/1 | CapsuleOral | Ascend Laboratories, LLC | 67877-754 | 67877-0754-60 |
| Dronabinol | Dronabinol 2.5 mg/1 | CapsuleOral | Major Pharmaceuticals | 0904-7144 | 00904-7144-61 |
| Dronabinol | Dronabinol 2.5 mg/1 | CapsuleOral | Camber Pharmaceuticals Inc | 31722-960 | 31722-0960-60 |
| Dronabinol | Dronabinol 5 mg/1 | CapsuleOral | Camber Pharmaceuticals Inc | 31722-961 | 31722-0961-60 |
| Dronabinol | Dronabinol 10 mg/1 | CapsuleOral | Camber Pharmaceuticals Inc | 31722-962 | 31722-0962-60 |
| Dronabinol | Dronabinol 5 mg/mL | SolutionOral | Chartwell RX, LLC | 62135-033 | 62135-0033-43 |
Other NDCs under NDA 018651
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Dronabinol | Dronabinol 2.5 mg/1 | CapsuleOral | Ascend Laboratories, LLC | 67877-753 |
| Dronabinol | Dronabinol 5 mg/1 | CapsuleOral | Ascend Laboratories, LLC | 67877-754 |
| Dronabinol | Dronabinol 2.5 mg/1 | CapsuleOral | Major Pharmaceuticals | 0904-7144 |
| Dronabinol | Dronabinol 5 mg/1 | CapsuleOral | Major Pharmaceuticals | 0904-7145 |
| Marinoldronabinol | Dronabinol 5 mg/1 | CapsuleOral | ThePharmaNetwork, LLC | 53097-569 |
| Marinoldronabinol | Dronabinol 2.5 mg/1 | CapsuleOral | ThePharmaNetwork, LLC | 53097-568 |
| Marinoldronabinol | Dronabinol 5 mg/1 | CapsuleOral | ThePharmaNetwork, LLC | 53097-572 |
| Marinoldronabinol | Dronabinol 10 mg/1 | CapsuleOral | ThePharmaNetwork, LLC | 53097-570 |
| Marinoldronabinol | Dronabinol 2.5 mg/1 | CapsuleOral | ThePharmaNetwork, LLC | 53097-571 |
| Marinoldronabinol | Dronabinol 10 mg/1 | CapsuleOral | ThePharmaNetwork, LLC | 53097-573 |